Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema
John Hall Medical Affairs, Alimera Sciences Ltd., Aldershot, Hampshire, UKI read “Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials” published in May 2015 by Liu et al.1 The purpose of...
Main Author: | Hall J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/letter-efficacy-and-safety-of-different-doses-of-a-slow-release-c-peer-reviewed-article-DDDT |
Similar Items
-
Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
by: William Fusi-Rubiano, et al.
Published: (2018-09-01) -
Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
by: Saedon H, et al.
Published: (2017-03-01) -
Corticosteroids for diabetic macular edema
by: Jorge Chawan-Saad, et al.
Published: (2019-01-01) -
Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01) -
Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
by: Massin P, et al.
Published: (2016-07-01)